Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-18

Clinical Trial Update: Evaluating the Efficacy of Intranasal Oxytocin Among Individuals With Persistent Pain [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating intranasal oxytocin for chronic and pelvic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (intranasal) (oxytocin)

Snippet

Sponsor: University of Calgary | Conditions: Chronic Pain, Pelvic Pain | Phase 2, Phase 3 | Status: COMPLETED